4//SEC Filing
Cagle Gerald D. 4
Accession 0001209191-18-039537
CIK 0001539029other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 6:01 PM ET
Size
11.7 KB
Accession
0001209191-18-039537
Insider Transaction Report
Form 4
Cagle Gerald D.
Director
Transactions
- Exercise/Conversion
Common Stock
2018-06-25$8.81/sh+8,618$75,925→ 77,513 total - Exercise/Conversion
Common Stock
2018-06-25$9.11/sh+2,632$23,978→ 80,145 total - Exercise/Conversion
Stock Option (right to buy)
2018-06-25−8,618→ 0 totalExercise: $8.81From: 2018-06-20Exp: 2027-06-21→ Common Stock (8,618 underlying) - Exercise/Conversion
Stock Option (right to buy)
2018-06-25−2,632→ 0 totalExercise: $9.11From: 2018-06-20Exp: 2027-06-29→ Common Stock (2,632 underlying)
Holdings
- 14,064(indirect: See Footnote)
Common Stock
Footnotes (1)
- [F1]Cagle Business Interests, Ltd. is the record holder of these securities. The reporting person is the general partner of Cagle Business Interests, Ltd. and may be deemed to share voting and dispositive power over these securities. The reporting person disclaims beneficial ownership of these securities and this report is not an admission that the reporting person is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
Documents
Issuer
Clearside Biomedical, Inc.
CIK 0001539029
Entity typeother
Related Parties
1- filerCIK 0001589991
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 6:01 PM ET
- Size
- 11.7 KB